Nuvalent Ownership | Who Owns Nuvalent?
Nuvalent Ownership Summary
Nuvalent is owned by 44.08% institutional investors, 2.80% insiders, and 53.12% retail investors. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 25.04% of NUVL shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.52% of its assets in Nuvalent shares.
NUVL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Nuvalent | 44.08% | 2.80% | 53.12% |
Sector | Healthcare Stocks | 479.67% | 11.03% | -390.70% |
Industry | Biotech Stocks | 295.80% | 10.97% | -206.77% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Deerfield management company, l.p. (series c) | 17.99M | 25.04% | $1.37B |
Fmr | 9.65M | 14.70% | $755.74M |
Paradigm biocapital advisors lp | 5.27M | 7.36% | $373.71M |
Vanguard group | 4.50M | 6.85% | $352.25M |
Blackrock funding, inc. /de | 4.05M | 5.63% | $308.73M |
Blackrock | 3.02M | 4.71% | $229.37M |
Commodore capital lp | 1.85M | 2.59% | $131.56M |
State street | 1.33M | 2.07% | $100.59M |
Bain capital life sciences investors | 1.45M | 2.01% | $110.43M |
Price t rowe associates inc /md/ | 1.30M | 1.98% | $101.60M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Deerfield management company, l.p. (series c) | 17.99M | 24.91% | $1.37B |
Paradigm biocapital advisors lp | 5.27M | 17.12% | $373.71M |
Bain capital life sciences investors | 1.45M | 13.82% | $110.43M |
Commodore capital lp | 1.85M | 9.69% | $131.56M |
Fairmount funds management | 727.56K | 7.19% | $55.51M |
First turn management | 331.93K | 4.75% | $23.54M |
Boxer capital | 1.12M | 4.48% | $84.98M |
Affinity asset advisors | 415.00K | 4.32% | $31.66M |
Vestal point capital, lp | 1.07M | 4.32% | $82.02M |
Perceptive advisors | 1.38M | 3.89% | $104.93M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
T. rowe price investment management | 1.09M | 0.05% | 643.79K |
Vanguard group | 4.50M | 0.01% | 366.24K |
Braidwell lp | 1.18M | 3.07% | 334.93K |
Norges bank | 318.74K | 0.00% | 318.74K |
Blackrock | 3.02M | 0.01% | 315.17K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Darwin global management | - | - | -1.44M |
Logos global management lp | - | - | -500.00K |
Marshall wace, llp | 61.49K | 0.01% | -360.03K |
Rock springs capital management lp | 93.33K | 0.44% | -334.20K |
Driehaus capital management | 216.42K | 0.13% | -314.79K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 318.74K | 0.00% | 318.74K | $24.95M |
Baker bros. advisors lp | 143.94K | 0.11% | 143.94K | $10.98M |
Alps advisors | 35.78K | 0.02% | 35.78K | $2.73M |
Readystate asset management lp | 23.59K | 0.06% | 23.59K | $1.80M |
Natixis | 22.92K | 0.01% | 22.92K | $1.75M |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Stephens consulting | -10.00 |
Lynx investment advisory | -15.00 |
Nelson, van denburg & campbell wealth management group | -16.00 |
Parallax volatility advisers | -16.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 17 | -92.58% | 31,565,284 | -55.28% | 44 | 0.38% | 7 | -95.17% | 7 | -85.71% |
Dec 31, 2024 | 226 | 8.65% | 70,521,617 | 0.93% | 107 | 0.95% | 142 | 17.36% | 49 | -10.91% |
Sep 30, 2024 | 208 | 16.85% | 69,868,503 | 6.54% | 106 | 1.02% | 122 | 24.49% | 54 | - |
Jun 30, 2024 | 178 | -3.78% | 65,581,790 | 3.58% | 102 | 1.05% | 98 | -8.41% | 54 | -6.90% |
Mar 31, 2024 | 185 | 9.47% | 63,315,326 | -0.47% | 98 | 0.83% | 107 | -10.83% | 58 | 141.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl O | 2.49M | 3.52% | - |
Fidelity Growth Compy Commingled Pl S | 2.44M | 3.39% | 2.32K |
Fidelity Growth Company Fund | 1.73M | 2.40% | - |
Vanguard Total Stock Mkt Idx Inv | 1.46M | 2.03% | -31.09K |
Vanguard Small Cap Index | 1.13M | 1.56% | -7.43K |
iShares Russell 2000 ETF | 1.01M | 1.41% | -19.32K |
Vanguard Small Cap Value Index Inv | 727.18K | 1.01% | 2.80K |
Fidelity Select Health Care | 700.00K | 0.97% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 593.56K | 0.83% | 2.17K |
SPDR® S&P Biotech ETF | 587.43K | 0.82% | 14.46K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 15, 2025 | Porter James Richard | President and CEO | Sell | $521.60K |
Aug 15, 2025 | Porter James Richard | President and CEO | Sell | $7.69K |
Aug 15, 2025 | Porter James Richard | President and CEO | Sell | $1.51M |
Aug 07, 2025 | Pelish Henry E. | Chief Scientific Officer | Sell | $411.68K |
Jul 30, 2025 | Noci Darlene | Chief Development Officer | Sell | $321.44K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 15 |
2025 Q2 | - | 20 |
2025 Q1 | - | 41 |
2024 Q4 | - | 33 |
2024 Q3 | - | 73 |
NUVL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools